BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao J, Chang C, Wu H, Lu Q. Cell-based therapies for systemic lupus erythematosus. Autoimmun Rev 2015;14:43-8. [PMID: 25308529 DOI: 10.1016/j.autrev.2014.10.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Escobar-Soto CH, Mejia-Romero R, Aguilera N, Alzate-Granados JP, Mendoza-Pinto C, Munguía-Realpozo P, Méndez-Martínez S, García-Carrasco M, Rojas-Villarraga A. Human mesenchymal stem cells for the management of systemic sclerosis. Systematic review. Autoimmun Rev 2021;20:102831. [PMID: 33878487 DOI: 10.1016/j.autrev.2021.102831] [Reference Citation Analysis]
2 Zhu Q, Li Y, Zhang L, Wang M, Chen Z, Shi J, Li J, Li B, Li Z, Wang Y, Xie C. Patients with systemic lupus erythematosus show increased proportions of CD19+CD20- B cells and secretion of related autoantibodies. Clin Rheumatol 2021;40:151-65. [PMID: 32542581 DOI: 10.1007/s10067-020-05220-2] [Reference Citation Analysis]
3 Xu J, Chen J, Li W, Lian W, Huang J, Lai B, Li L, Huang Z. Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus. J Am Soc Nephrol 2020;31:54-65. [PMID: 31604808 DOI: 10.1681/ASN.2019050545] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
4 Horuluoglu B, Bayik D, Kayraklioglu N, Goguet E, Kaplan MJ, Klinman DM. PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus. J Autoimmun 2019;99:24-32. [PMID: 30679006 DOI: 10.1016/j.jaut.2019.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
5 Tan K, Zheng K, Li D, Lu H, Wang S, Sun X. Impact of adipose tissue or umbilical cord derived mesenchymal stem cells on the immunogenicity of human cord blood derived endothelial progenitor cells. PLoS One 2017;12:e0178624. [PMID: 28562647 DOI: 10.1371/journal.pone.0178624] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
6 Zeher M, Papp G, Nakken B, Szodoray P. Hematopoietic stem cell transplantation in autoimmune disorders: From immune-regulatory processes to clinical implications. Autoimmun Rev. 2017;16:817-825. [PMID: 28572052 DOI: 10.1016/j.autrev.2017.05.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
7 Gao S, Gong Y, Ji J, Yuan L, Han L, Guo Y, Fan X, Hou Y, Hua C. A new benzenediamine derivative modulates Toll-like receptors-induced myeloid dendritic cells activation and ameliorates lupus-like syndrome in MRLlpr/lpr mice. Eur J Pharmacol 2017;803:94-102. [PMID: 28342978 DOI: 10.1016/j.ejphar.2017.03.048] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Papp G, Boros P, Nakken B, Szodoray P, Zeher M. Regulatory immune cells and functions in autoimmunity and transplantation immunology. Autoimmunity Reviews 2017;16:435-44. [DOI: 10.1016/j.autrev.2017.03.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
9 Huang L, Yang Y, Kuang Y, Wei D, Li W, Yin Q, Pang J, Zhang Z. The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation. J Immunol Res 2016;2016:5183686. [PMID: 28044142 DOI: 10.1155/2016/5183686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Jamin C, Le Lann L, Alvarez-errico D, Barbarroja N, Cantaert T, Ducreux J, Dufour AM, Gerl V, Kniesch K, Neves E, Trombetta E, Alarcón-riquelme M, Marañon C, Pers J. Multi-center harmonization of flow cytometers in the context of the European “PRECISESADS” project. Autoimmunity Reviews 2016;15:1038-45. [DOI: 10.1016/j.autrev.2016.07.034] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
11 Rostamzadeh D, Razavi SR, Esmaeili S, Dolati S, Ahmahi M, Sadreddini S, Jadidi-niaragh F, Yousefi M. Application of nanoparticle technology in the treatment of Systemic lupus erythematous. Biomedicine & Pharmacotherapy 2016;83:1154-63. [DOI: 10.1016/j.biopha.2016.08.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
12 He YY, Yan Y, Zhang HF, Lin YH, Chen YC, Yan Y, Wu P, Fang JS, Yang SH, Du GH. Methyl salicylate 2-O-β-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction. Drug Des Devel Ther 2016;10:3183-96. [PMID: 27729775 DOI: 10.2147/DDDT.S114501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Selmi C. Autoimmunity in 2015. Clinic Rev Allerg Immunol 2016;51:110-9. [DOI: 10.1007/s12016-016-8576-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
14 Favoino E, Prete M, Marzullo A, Millo E, Shoenfeld Y, Perosa F. CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases. Clinic Rev Allerg Immunol 2017;52:217-33. [DOI: 10.1007/s12016-016-8551-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
15 Maria ATJ, Maumus M, Le Quellec A, Jorgensen C, Noël D, Guilpain P. Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis. Clinic Rev Allerg Immunol 2017;52:234-59. [DOI: 10.1007/s12016-016-8552-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 8.7] [Reference Citation Analysis]
16 Jin H, Zhang G, Zhou Y, Chang C, Lu Q. Old lines tell new tales: Blaschko linear lupus erythematosis. Autoimmunity Reviews 2016;15:291-306. [DOI: 10.1016/j.autrev.2015.11.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang C, Guo W, Cai D, Wang X, Yu D, Gao X, Yao W. A truncated IL-12rβ1 receptor ameliorates chronic graft-versus-host disease-induced lupus nephritis by inhibiting Th1 and Th17 cells. International Immunopharmacology 2015;29:544-51. [DOI: 10.1016/j.intimp.2015.09.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Podolska MJ, Biermann MH, Maueröder C, Hahn J, Herrmann M. Inflammatory etiopathogenesis of systemic lupus erythematosus: an update. J Inflamm Res 2015;8:161-71. [PMID: 26316795 DOI: 10.2147/JIR.S70325] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]